Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 27;9(1):2.
doi: 10.1186/s13065-015-0079-2. eCollection 2015.

Phytochemical and pharmacological progress on the genus Syringa

Guozhu Su  1 , Yuan Cao  1 , Chun Li  2 , Xuelong Yu  1 , Xiaoli Gao  2 , Pengfei Tu  2 , Xingyun Chai  2
Affiliations

Phytochemical and pharmacological progress on the genus Syringa

Guozhu Su et al. Chem Cent J. .

Abstract

Genus Syringa, belonging to the Oleaceae family, consists of more than 40 plant species worldwide, of which 22 species, including 18 endemic species, are found in China. Most Syringa plants are used in making ornaments and traditional medicines, whereas some are employed for construction or economic use. Previous studies have shown that extracts of Syringa plants mainly contain iridoids, lignans, and phenylethanoids that have antitumor, antihypertensive, anti-oxidant, and anti-inflammatory activities. This study reviews phytochemical and pharmacological progress on Syringa in the recent 20 years and discusses the future research prospects to provide a reference in further promotion and application of the genus. Graphical AbstractPhytochemical and pharmacological progress on the genus Syringa.

Keywords: Bioactivities; Iridoid; Lignan; Oleaceae; Phenylethanoid; Review; Syringa.

PubMed Disclaimer

Figures

Graphical Abstract
Graphical Abstract
Phytochemical and pharmacological progress on the genus Syringa
Figure 1
Figure 1
The structures of iridoids from the genus Syringa .
Figure 2
Figure 2
The structures of lignans from the genus Syringa .
Figure 3
Figure 3
The structures of other type of compounds from the genus Syringa .
See this image and copyright information in PMC

References

    1. Editorial Committee of Chinese Material Medica Chinese Material Medica-Mongolian volume. Shanghai Sci Technol Press. 1992;61:2–50.
    1. Zhang JF, Zhang SJ. An overview of the genus Syringa: phytochemical and pharmacological aspects. Nat Sci J Hainan Univ. 2007;2:201–5.
    1. Deng RX, Yuan H, Liu P, Yin WP, Wang XS, Zhao TZ. Chemical constituents from Syringa pubescens Turcz. Biochem Syst Ecol. 2010;38:813–5. doi: 10.1016/j.bse.2010.08.004. - DOI
    1. Zhang GB, Liu LJ, Wang MK. Chemical constituents of volatile oils from Syringa pinnatifolia. Chin Pharm J. 1994;5:271.
    1. SamyK ED, GamalEldeen AM. Cytotoxic and anti-inflammatory activities of some constituents from the floral buds of Syringa patula. Pharm Biol. 2009;47:872–7. doi: 10.1080/13880200902950785. - DOI